Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

IGF2: an endocrine hormone to improve islet transplant survival.

Hughes A, Rojas-Canales D, Drogemuller C, Voelcker NH, Grey ST, Coates PT.

J Endocrinol. 2014 May;221(2):R41-8. Review.

2.

Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene.

Contreras JL, Bilbao G, Smyth CA, Jiang XL, Eckhoff DE, Jenkins SM, Thomas FT, Curiel DT, Thomas JM.

Transplantation. 2001 Apr 27;71(8):1015-23.

PMID:
11374395
3.

Gene therapy to improve pancreatic islet transplantation for Type 1 diabetes mellitus.

Hughes A, Jessup C, Drogemuller C, Mohanasundaram D, Milner C, Rojas D, Russ GR, Coates PT.

Curr Diabetes Rev. 2010 Sep;6(5):274-84. Review.

PMID:
20594165
4.

Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.

Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C.

Transplantation. 2002 Dec 27;74(12):1761-6.

PMID:
12499894
5.

Insulin-Like growth factor-II (IGF-II) prevents proinflammatory cytokine-induced apoptosis and significantly improves islet survival after transplantation.

Hughes A, Mohanasundaram D, Kireta S, Jessup CF, Drogemuller CJ, Coates PT.

Transplantation. 2013 Mar 15;95(5):671-8. doi: 10.1097/TP.0b013e31827fa453.

PMID:
23364485
6.

Alpha-melanocyte stimulating hormone preserves islet graft survival through down-regulation of Toll-like receptors.

Jung EJ, Kim SC, Jeong SH, Lee JY, Han DJ.

Transplant Proc. 2012 May;44(4):1086-90. doi: 10.1016/j.transproceed.2012.02.018.

PMID:
22564632
7.
8.

Donor pretreatment with DHMEQ improves islet transplantation.

Takahashi T, Matsumoto S, Matsushita M, Kamachi H, Tsuruga Y, Kasai H, Watanabe M, Ozaki M, Furukawa H, Umezawa K, Todo S.

J Surg Res. 2010 Sep;163(1):e23-34. doi: 10.1016/j.jss.2010.04.044. Epub 2010 May 21.

PMID:
20638688
9.

Mitomycin-C treatment followed by culture produces long-term survival of islet xenografts in a rat-to mouse model.

Gunji T, Saito T, Sato Y, Matsuyama S, Ise K, Kimura T, Anazawa T, Gotoh M.

Cell Transplant. 2008;17(6):619-29.

PMID:
18819250
10.

Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines.

Yeung TY, Seeberger KL, Kin T, Adesida A, Jomha N, Shapiro AM, Korbutt GS.

PLoS One. 2012;7(5):e38189. doi: 10.1371/journal.pone.0038189. Epub 2012 May 30.

11.

Insulin treatment of mice recipients preserves beta-cell function in porcine islet transplantation.

Pakhomov O, Honiger J, Gouin E, Cariolet R, Reach G, Darquy S.

Cell Transplant. 2002;11(7):721-8.

PMID:
12518899
12.

Cell permeable peptide of JNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function.

Noguchi H, Nakai Y, Matsumoto S, Kawaguchi M, Ueda M, Okitsu T, Iwanaga Y, Yonekawa Y, Nagata H, Minami K, Masui Y, Futaki S, Tanaka K.

Am J Transplant. 2005 Aug;5(8):1848-55.

13.

Glial cell line-derived neurotrophic factor enhances human islet posttransplantation survival.

Mwangi SM, Usta Y, Shahnavaz N, Joseph I, Avila J, Cano J, Chetty VK, Larsen CP, Sitaraman SV, Srinivasan S.

Transplantation. 2011 Oct 15;92(7):745-51. doi: 10.1097/TP.0b013e31822bc95a.

14.

The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.

Yang Z, Chen M, Ellett JD, Fialkow LB, Carter JD, Nadler JL.

Transplantation. 2004 Jan 15;77(1):55-60.

PMID:
14724435
15.

Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death.

Garcia-Ocana A, Takane KK, Reddy VT, Lopez-Talavera JC, Vasavada RC, Stewart AF.

J Biol Chem. 2003 Jan 3;278(1):343-51. Epub 2002 Oct 25.

16.

XIAP overexpression in islet beta-cells enhances engraftment and minimizes hypoxia-reperfusion injury.

Emamaullee J, Liston P, Korneluk RG, Shapiro AM, Elliott JF.

Am J Transplant. 2005 Jun;5(6):1297-305. Review.

17.
18.

17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality.

Contreras JL, Smyth CA, Bilbao G, Young CJ, Thompson JA, Eckhoff DE.

Transplantation. 2002 Nov 15;74(9):1252-9.

PMID:
12451262
19.

IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo.

Choi SE, Choi KM, Yoon IH, Shin JY, Kim JS, Park WY, Han DJ, Kim SC, Ahn C, Kim JY, Hwang ES, Cha CY, Szot GL, Yoon KH, Park CG.

Transpl Immunol. 2004 Jun-Jul;13(1):43-53.

PMID:
15203128
20.

Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy.

Machen J, Bertera S, Chang Y, Bottino R, Balamurugan AN, Robbins PD, Trucco M, Giannoukakis N.

Gene Ther. 2004 Oct;11(20):1506-14.

PMID:
15229635

Supplemental Content

Support Center